李益民

All filings by 李益民 on record concern 万泰生物, in the capacity of senior executive. In total, 3 filings cover trades dated from 26 May 2021 to 11 June 2021.

No open-market purchase appears, only 3 sales worth €18.9M.

The latest filing, published on 11 June 2021, reports an open-market sale of €1.9M in 万泰生物. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.